Subrata Panda &Amp; Sohini Das

Stories by Subrata Panda &Amp; Sohini Das

Govt now allows doorstep delivery of drugs

Govt now allows doorstep delivery of drugs

Rediff.com   27 Mar 2020

Medicines that fall under Schedule H category (class of prescription drugs) would be provided against a valid prescription that can be submitted either physically or over e-mail. Narcotics, psychotropics and controlled substances, though, cannot be delivered.

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Rediff.com   20 Mar 2020

Retailers and multiplex operators want mall owners to either forgo rent for the period of the shutdown or lower rent in the event the mall is open but footfalls are low.

NCLT grants 90-day extension to Jet

NCLT grants 90-day extension to Jet

Rediff.com   19 Mar 2020

This is an exceptional case of extension beyond the 330-day limit under the insolvency and bankruptcy code.

How companies deal with coronavirus panic

How companies deal with coronavirus panic

Rediff.com   17 Mar 2020

Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.

Coronavirus fear robs malls, multiplexes of Holi colour

Coronavirus fear robs malls, multiplexes of Holi colour

Rediff.com   8 Mar 2020

'There is a clear business impact. People are avoiding crowded places and gatherings across cities. This is hitting business, both at traditional and modern trade outlets, during the Holi season, which kicked off from Saturday,' says Praveen Khandelwal, general secretary, Confederation of All India Traders (CAIT).

How much is YES Bank stock worth?

How much is YES Bank stock worth?

Rediff.com   6 Mar 2020

Foreign brokerages said if SBI decide to buy stake in the bank, they should buy it at Rs 1 per share as the net worth is hugely impaired.

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com   4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

RBI urges PSBs to take steps to increase credit growth

RBI urges PSBs to take steps to increase credit growth

Rediff.com   3 Mar 2020

Bank credit growth declined to 8.5 per cent in January from 13.5 per cent in the year-ago period.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com   20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Jet gets another EoI; deadline for resolution plan extended

Jet gets another EoI; deadline for resolution plan extended

Rediff.com   19 Feb 2020

A Russian fund submitted its interest to the resolution professional on February 14 and also hired a consultancy firm to help them with the bidding process.

LIC's gross NPA ratio in debt portfolio rises to 7.5% in Dec

LIC's gross NPA ratio in debt portfolio rises to 7.5% in Dec

Rediff.com   18 Feb 2020

In absolute terms, the outstanding book value of NPAs of LIC in the debt portfolio across life, pension and unit-linked funds is to the tune of Rs 32,685.39 crore at the end of December 2019.

Kohli is top celebrity brand for third time in a row

Kohli is top celebrity brand for third time in a row

Rediff.com   17 Feb 2020

The Duff & Phelps report shows that Virat Kohli has increased his brand value by 40 per cent to $237.5 million in 2019 and taken a huge lead with his closest rival, Akshay Kumar, ranked second.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com   12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com   12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

For LIC, road to bourses won't be easy

For LIC, road to bourses won't be easy

Rediff.com   10 Feb 2020

Amendment to the Act, sovereign guarantees, investment portfolio, realty holdings, and governance issues to shape valuation.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com   7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.

LIC's exposure to default debt instruments tops Rs 20,000 crore

LIC's exposure to default debt instruments tops Rs 20,000 crore

Rediff.com   23 Jan 2020

The exposure, which is for the period ended September 2019, is across various platforms such as life funds, pension funds, and unit-linked funds.

Jet Airways gets two suitors; Hindujas back out

Jet Airways gets two suitors; Hindujas back out

Rediff.com   16 Jan 2020

South America-based Synergy Group, one of the suitors, has said slots at London's Heathrow airport are critical to the airline's operations and will decide on participating in the resolution only if it gets clarity. It also wants to form a new company with its assets, employees, and operating permit but minus all liabilities.

Adamant Trai says will implement new tariff order by March 1

Adamant Trai says will implement new tariff order by March 1

Rediff.com   14 Jan 2020

Reiterating its position, TRAI, which oversees both the telecom and television sectors in the country, said the amendments suggested on January 1 had been done to correct "distortions" in the market and address pricing issues.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com   13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.